Management Team
Richard L. Klein
President / Director/ Founder
Mr. Klein has served as President and Director of Medlogics Device Corporation since co-founding it in August 2002. From October 2001 to May 2003, Mr. Klein also served as Corporate Counsel for Bioheart, Inc. and Director of Biopace, Inc. Prior to this, Mr. Klein was co-founder, COO, General Counsel and Director of MitraLife, Inc. (subsequently acquired by ev3, Inc.) from May 2000 to July 2001. Mr. Klein also served as Vice President and Chief Patent Counsel for Arterial Vascular Engineering, Inc. (subsequently acquired by Medtronic, Inc.) from June 1996 to June 2000. Prior to that, Mr. Klein was an attorney with the law firm of Fischbach, Perlstein and Yanny from May 1994 to May 1996. Mr. Klein also served as Assistant Patent Counsel at the California Institute of Technology and Jet Propulsion Laboratory from January 1989 through April 1994. Prior to that, Mr. Klein served as an Examiner with the United States Patent and Trademark Office from June 1982 to September 1988. Mr. Klein holds a B.S. degree from the State University of New York at Buffalo and a J.D. degree from the Southwestern University School of Law. Mr. Klein is a member of the California and District of Columbia bars, is registered to practice before the United States Patent and Trademark Office and is admitted to practice before numerous federal district and appellate courts.
Majid Akhavan
Director, Analytical Chemistry
Prior to his appointment as Director, Majid served as a consultant for Medlogics the past two years. From 2004-2007, he was founder and Managing Director of Pacific Analytical Laboratory serving pharmaceutical and environmental companies. Prior to this, Mr. Akhavan served as a Manager of Bioanalytical Department at Cerus Corporation where he headed all Bioanalytical activities and additionally he served in multidisciplinary activities from research to manufacturing (CGMP) oversight. From 1987-1998 Majid served as Team Leader and project manager for Astera Zeneca. He has a Master of Science degree in Chemistry with three years post graduate research in Medicinal Chemistry at UC Davis.
Kenneth J. Colley, M.D., Ph.D.
Vice President, Pharmaceutical Product Development
Dr. Colley is an accomplished physician-scientist-entrepreneur with over 18 years experience in medicine, the life sciences industry, pharmaceutical product development, and bioventure formation and funding. Ken most recently was V.P. Product Development for OsteoGenix Inc., a start-up orthobiologics company, while serving on the development team at Shalon Ventures in Palo Alto. In 2004, Dr. Colley joined Medlogics as Chief Scientific Officer concurrent with its deal acquiring assets of BioVasc Inc., an emerging convergence technology company developing cardiovascular products at the intersection of biopharmaceuticals and medical devices, which he founded in 2003. Dr. Colley was formerly the founding CEO and technology director of Angiogenix Inc., raising over $20 million from start-up in 1998 through early clinical trial phases prior to his departure to form BioVasc in 2003. Prior to Angiogenix, Dr. Colley worked at Cygnus Inc. designing advanced drug delivery systems. He received his M.D. from Georgetown University, subsequently training in Internal Medicine at Johns Hopkins University, and also received his Ph.D. in Molecular Pharmacology from Georgetown University. He holds a B.S. in Biological Sciences with a mechanical engineering minor from Stanford University.
Kendra Des-Bordes
Director, Operations
Ms. Des-Bordes’ tenure at Medlogics Device Corporation began in February 2004, serving as Director of Operations since March 2008. Prior to Medlogics, Ms. Des-Bordes was the Corporate Document Control Manager at Bioheart, a company developing percutaneous thoracoscopic and surgical myocardial systems from June 2001 to June 2003. From January 1994 to June 2001 she worked in various capacities with Arterial Vascular Engineering (acquired by Medtronic in 1999), and Medtronic Vascular from Manufacturing and Pilot Production to Research and Development, and Quality Assurance, including the position of Supervisor of Advanced Development.
Kalei Hampson, M.B.A.
Director, Marketing
Mr. Hampson has served as the Director of Marketing since October 2007 and has over 16 years experience within the life science and healthcare industries. Mr. Hampson comes to Medlogics Device Corporation from Medtronic CardioVascular where he helped lead their Peripheral business from December 2003 to September 2007. Prior to his involvement with the vascular market Mr. Hampson obtained 6 years of sales and marketing experience in hematology/oncology with BioTransplant and Baxter Healthcare. Mr. Hampson founded BDM Consulting where he successfully enabled his clients to meet their business development and marketing needs. Mr. Hampson’s career began in sales in life sciences with VWR Scientific Products and later with SciQuest.com. Mr. Hampson obtained his M.B.A. from Pepperdine University and undergraduate degree in Political Science from the University of California at Santa Barbara.
Michael J. Lee
Vice President, Engineering
Mr. Lee has headed Medlogics Research and Development, Equipment, and Facilities since August 2003. He has more than 14 years of medical device experience. Prior to Medlogics, Mr. Lee was the Director of Research and Development of Bioheart’s hybrid percutaneous, thoracoscopic, and surgical myocardial regeneration injection systems, where he started and headed the device division. Prior to Bioheart, Mr. Lee was in R&D for Cardeon Corporation, responsible for research and development of innovative blood return cannulae with cerebral protection using differential flow and temperature. Prior to Cardeon, he was in R&D for Arterial Vascular Engineering, Inc. (subsequently acquired by Medtronic, Inc) working on stents, stent delivery systems and angioplasty devices for coronary and peripheral indications; and was instrumental in the growth from about 30 to 3000 employees over 4 years. Prior to AVE, he worked in R&D at Cardiac Pathways Corporation (subsequently acquired by Boston Scientific Corp.) on innovative electrophysiology systems with integrated cooling. Mr. Lee has several patents issued and several that are pending. He has a B.S. in Mechanical Engineering from California Polytechnic State University, San Luis Obispo.
Joseph R. Tamayo
Vice President, Regulatory Affairs and Quality Assurance
Mr. Tamayo has led the Regulatory and Quality Organizations for Medlogics Device Corporation since August 2003. He has more than 15 years of regulatory and quality experience in the medical device industry. Prior to Medlogics, Mr. Tamayo served as Director of Regulatory and Quality for Bioheart, Incorporated, a hybrid biotechnology start-up, where he headed all regulatory and quality functions. Prior to this, Mr. Tamayo served as Manager of Regulatory Affairs for Cerus Corporation, a hybrid biotechnology start-up developing transfusion products. Prior to Cerus, Mr. Tamayo served in various regulatory capacities, with increasing responsibility, including Regulatory Affairs Program Manager at Arterial Vascular Engineering, Inc. (subsequently acquired by Medtronic, Inc). Before joining Arterial Vascular Engineering, Inc., Mr. Tamayo served in various regulatory, clinical and pre-clinical capacities in the ophthalmic device industry. Mr. Tamayo received his Bachelor of Science Degree in Biology from Loyola Marymount University.
John (Jack) Thomas, RN
Vice-President, Clinical Affairs
Mr. Thomas joined Medlogics as the Vice-President of Clinical Affairs as of March, 2008 and has over 30-years of experience in healthcare. From 1992- 1996, Mr. Thomas worked as an education/training specialist and as the international training manager with Heart Technology and then with Boston Scientific upon acquisition of the company. From 1996- 1999, he worked as an education specialist with Arterial Vascular Engineering (AVE)/Medtronic where he set up and initiated a clinical study resulting in FDA approval for a renal stent in 2002. Mr. Thomas served as the director of clinical affairs at PharmaSpec Corporation from September 1999 until March 2002 developing a drug-delivery catheter for use in diabetic patients. From April 2002 until December 2003, Mr. Thomas worked as Director of Clinical research with TransVascular, Inc. until its acquisition by Medtronic Vascular where he worked until February 2008 as clinical research manager for peripheral clinical studies leading his clinical study team to a successful FDA PMA submission and approval for a carotid stent in 2007. In addition to more than 15 years of managing clinical research studies, Mr. Thomas has been licensed as a registered nurse (RN) in California and Massachusetts for more than 30 years, with 7 years of cardiac cath lab experience in California and Italy. He received a degree in nursing from Massasoit Community College in Brockton, MA and a Bachelor of Science degree from Excelsior College in Albany, NY.